title: FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis.
authors: breccia@bce.uniroma1.it.
authors: Massimo
authors: M
authors: Breccia
authors: Giuseppina
authors: G
authors: Loglisci
authors: Maria Giovanna
authors: MG
authors: Loglisci
authors: Roberto
authors: R
authors: Ricci
authors: Daniela
authors: D
authors: Diverio
authors: Roberto
authors: R
authors: Latagliata
authors: Robin
authors: R
authors: Foà
authors: Francesco
authors: F
authors: Lo-Coco
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D011379:Prognosis; D011446:Prospective Studies; D020080:Tandem Repeat Sequences / Q000235:genetics*; D013997:Time Factors; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics*
chemical_list: D014212:Tretinoin; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3; D015255:Idarubicin
keywords: FLT3; acute promyelocytic leukemia; internal tandem duplication; poor prognosis